Saturday 17 October 2026
Export GKOS’s income statement to Excel — free account
Glaukos Corporation
GKOS Healthcare Medical Devices
Glaukos Corporation’s revenue for fiscal 2025 (year ended December 2025) was $507.4 million, up 32.3% from fiscal 2024. In the quarter to June 2026, revenue grew 49.5%, EPS grew 8.82%, free cash flow grew 211.8% and total debt fell 2.15%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
164.84
0.76
−0.46%
Follow GKOS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 3 | 3 | 4 |
| (12.19%) | (26.38%) | (26.39%) | (25.98%) | ||
| (9.10%) | (20.09%) | (20.36%) | (19.72%) | ||
ROIC |
(9.79%) | (28.00%) | (26.89%) | (26.07%) | |
Return on Tangible Assets |
(18.32%) | (38.54%) | (37.21%) | (35.78%) | |
Average Days of Receivables |
76.67 | 78.12 | 79.24 | 82.73 | |
Free Cash Flow per Share |
(0.77) | (0.68) | (0.60) | (0.21) | |
Free Cash Flow |
(44.22) | (39.06) | (35.09) | (12.20) | |
Capital Expenditures |
(23.09) | (24.27) | (26.29) | (11.25) | |
| Other line items | |||||
Cash ROIC |
(3.98%) | (3.89%) | (3.46%) | (1.18%) | |
Accounts Receivable Turnover |
6.06 | 5.99 | 5.77 | 5.52 | |
Accounts Payable Turnover |
7.01 | 5.94 | 6.91 | 7.80 | |
Inventory Turnover |
1.76 | 1.84 | 1.98 | 2.07 | |
Average Days of Payables |
66.78 | 80.38 | 57.85 | 54.59 | |
Days of Inventory on Hand |
214.49 | 207.50 | 188.44 | 169.17 | |
Tax Rate |
0.01 | (0.03) | (0.03) | (0.02) | |
Research and Development Expense of Revenue |
30.54% | 29.68% | 29.46% | 29.15% | |
Selling, General and Administrative Expense of Revenue |
65.14% | 65.38% | 64.21% | 63.10% | |
Share Based Compensation of Revenue |
12.61% | 12.46% | 12.58% | 13.09% | |
Interest Coverage |
(17.47) | (43.06) | (43.24) | (39.42) | |
Operating CF/Net income |
0.24 | 0.08 | 0.05 | 0.01 | |
Depreciation/Fixed assets |
0.32 | 0.35 | 0.39 | 0.40 | |
Capex/Depreciation |
(0.65) | (0.62) | (0.60) | (0.25) | |
Revenue per Share |
8.19 | 8.87 | 9.50 | 10.42 | |
Operating CF per Share |
(0.37) | (0.26) | (0.15) | (0.02) | |
Capex per Share |
(0.40) | (0.42) | (0.45) | (0.19) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.02 |
Columns are period end dates